Diabetes Center Hosting Pre-diabetes Education Series
CINCINNATIAre you at risk for diabetes? Do you have a family history of the disease?
If so, or if your physician has already diagnosed you with pre-diabetes, then join the Diabetes Center, part of UC Physicians, for a two-class series on pre-diabetes management.
A UC nutritionist and graduate student intern from UCs College of Allied Health Sciences will be on hand to discuss diabetes and answer questions about healthy lifestyle goals, weight management and metabolic syndrome.
The series begins Monday, May 4, 2009, and will conclude Monday, June 1, 2009. Morning or afternoon sessions are available. Each session is three hours long and will be held at the Diabetes Center, 3120 Burnet Ave., Suite 306.
Cost is $5 per person, per session, and includes all handouts and parking. No insurance is required. No referrals are needed.
For questions, or to register, call (513) 475-8200.
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.